The Catalyst

Special Edition Fact Check Friday: Why disclosing negotiated discounts and rebates won’t help patients

Posted by Holly Campbell on June 29, 2016 at 3:43 PM

In this special edition of Fact Check Friday, we’re focusing on why disclosing discounts and rebates negotiated between payers and biopharmaceutical manufacturers won’t help patients or lower out-of-pocket costs.

Read More

Topics: drug cost, Myths vs Facts, Fact Check

Science of Hope: Incorporating the patient perspective

Posted by Andrew Powaleny on June 29, 2016 at 8:00 AM

For many of America’s biopharmaceutical researchers and scientists, seeing the positive effects of their work on the lives of patients is what encourages them to keep striving.

Dr. Al Sandrock, chief medical officer at Biogen, recently shared his experiences working in the biopharmaceutical industry and how first-hand accounts from patients motivate him every day.

Read More

Topics: Patients, MS

Ask About Adherence: New resources from The Medication Adherence Alliance

Posted by Samantha Dougherty on June 28, 2016 at 9:00 AM

Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we spotlight a new website from The Medication Adherence Alliance, an organization comprised of representatives from consumer advocacy groups, community health providers, non-profit groups, the academic community, decision-making government officials and industry representatives.

Read More

Topics: adherence, #Adherence123s, Ask About Adherence

Medicare Monday: What is in the 2016 Medicare Trustees report

Posted by Allyson Funk on June 27, 2016 at 11:00 AM

Every year, the Trustees of the Social Security and Medicare trust funds release an annual report on the current and projected status of the two programs. The 2016 report on Medicare was released last week. Here are a few important things in the report:

Read More

Topics: Part D, Medicare, Medicare Monday

New PwC report finds medicine spending still small share of health spending, concerns may trigger ‘false alarms’

Posted by Holly Campbell on June 23, 2016 at 12:00 PM

In case you missed it, PwC Health Research Institute’s (HRI) Medical Cost Trend: Behind the Numbers 2017 report highlights medicine spending is “still a relatively small portion of overall health spending and, as such, concerns of ever-increasing cost growth from new cures may trigger false alarms.”

Read More

Topics: drug cost

Burden on patients: Access to medicines in health insurance exchange plans

Posted by Allyson Funk on June 23, 2016 at 9:00 AM

Access to prescription medicines is critical to help patients manage their chronic conditions and maximize quality of life. Unfortunately, even with insurance coverage, many patients still struggle to get the medicines they need due to high out-of-pocket costs and other plan restrictions. We looked at the burden on patients with health insurance exchange coverage in 2014 and 2015. Now, we’re taking a look at 2016 coverage.

Read More

Topics: Access, Cystic Fibrosis, health insurance, HIV/AIDS, Burden on Patients, Multiple Sclerosis, exchanges, Mental Health, Oncology, Access Better Coverage, ABCs of Coverage, Policy Solutions, Empower Consumers

Ask About Adherence: Q&A with PhRMA Foundation Grant Awardee - Marisa Schauerhamer

Posted by Samantha Dougherty on June 22, 2016 at 9:00 AM

Ask About Adherence is a blog series featuring Q&A’s with experts in medication adherence. In this post, we speak with Marisa Schauerhamer, a 2016 PhRMA Foundation Young Investigator Adherence grantee, about her research on how value-based insurance design affects medication adherence for patients with diabetes.

Read More

Topics: adherence, PhRMA Foundation, #Adherence123s, Ask About Adherence

Medicare Monday: What they are saying about MedPAC’s recommendations

Posted by Allyson Funk on June 20, 2016 at 12:00 PM

Back in April, we previewed MedPAC’s recommendations and expressed concern and opposition to the sweeping recommended changes to Part D that taken together could harm beneficiaries by eroding coverage and protections for many of the most vulnerable enrollees in the program.

Read More

Topics: Part D, Medicare, Medicare Monday

Science of Hope: Learning from setbacks

Posted by Andrew Powaleny on June 20, 2016 at 8:00 AM

America’s biopharmaceutical research companies are committed to developing new treatments and cures that improve health and save patient lives. Jen O’Neil, principal oncology scientist at Merck, recently shared her story about the importance of collaboration in the research and development process and how this environment inspires her despite the setbacks along the way.

Read More

Topics: Science, R&D, cancer, Drug Development, From Hope to Cures

Seizing the opportunity to rebuild U.S. leadership in STEM

Posted by Anne McDonald Pritchett, PhD on June 17, 2016 at 9:00 AM

The United States is not only falling behind other countries on many key science, technology, engineering and mathematics (STEM) indicators, but our public investment in STEM education has steadily declined at the same time that other countries—including our biggest global competitors—are making substantial investments. The choices we make now will impact America’s global competitiveness and economic growth for years to come.

Read More

Topics: STEM

I'd Like Updates


Posts by Topic

see more